The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction.

about

The Role of Vildagliptin in the Therapy of Type 2 Diabetic Patients with Renal Dysfunction.

Item

http://www.wikidata.org/entity/Q46304493

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The Role of Vildagliptin in th ...... tients with Renal Dysfunction.

@en

The Role of Vildagliptin in th ...... tients with Renal Dysfunction.

@nl

type

Item

label

The Role of Vildagliptin in th ...... tients with Renal Dysfunction.

@en

The Role of Vildagliptin in th ...... tients with Renal Dysfunction.

@nl

prefLabel

The Role of Vildagliptin in th ...... tients with Renal Dysfunction.

@en

The Role of Vildagliptin in th ...... tients with Renal Dysfunction.

@nl

P1476

The Role of Vildagliptin in th ...... tients with Renal Dysfunction.

@en

P2093

Roberto Trevisan

http://www.w3.org/2001/XMLSchema#string

P2860

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

Efficacy and tolerability of vildagliptin in type 2 diabetic patients on hemodialysis

Nephropathy in patients with type 2 diabetes mellitus.

Long-term effects of intensive glucose lowering on cardiovascular outcomes.

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

Hypoglycaemia, chronic kidney disease and death in type 2 diabetes: the Hong Kong diabetes registry

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes.

Evidence linking hypoglycemic events to an increased risk of acute cardiovascular events in patients with type 2 diabetes.

P2888

s13300-017-0302-3

P304

1215-1226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13300-017-0302-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roberto Trevisan

P577

2017-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28983844

http://www.w3.org/2001/XMLSchema#string

P932

5688978

http://www.w3.org/2001/XMLSchema#string